Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1C | P00326 | 4/20 | 0.35 |
| ▸ | ADH1A | P07327 | 4/20 | 0.35 |
| ▸ | ADH4 | P08319 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ADH1B | P00325 | 3/20 | 0.33 |
| ▸ | ADH7 | P40394 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27906062 | 0.91 | ADH1C (0.46) | ADH1CADH1AADH4TSHRADH1B | |
| SCHEMBL58555 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL8307302 | 0.83 | CA1 (0.35) | ADH1CADH1ACA12CA1CA2 | |
| SCHEMBL270774 | 0.82 | TSHR (0.35) | ADH1CADH1AADH4TSHRADH1B | |
| SCHEMBL8846294 | 0.79 | TSHR (0.37) | ADH1CADH1AADH4TSHRADH1B | |
| SCHEMBL23044912 | 0.77 | CA12 (0.35) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL271014 | 0.76 | ALDH1A1 (0.32) | CA12CA1CA9CA2 | |
| SCHEMBL19773664 | 0.74 | ADH1C (0.39) | ADH1CADH1AADH4TSHRADH1B | |
| SCHEMBL270711 | 0.74 | — | — | |
| SCHEMBL11033211 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022001649-A1 | PREPARATION METHOD FOR LEVETIRACETAM INTERMEDIATE | 浙江华海药业股份有限公司 | 2022-01-06 | — | — | WO | disclosed |
| US-8754010-B2 | Herbicidal mixtures | BASF AKTIENGESELLSCHAFT (DE) | 2014-06-17 | — | — | US | disclosed |
| EP-1697309-B1 | BENZOYL-SUBSTITUTED PHENYLALANINE AMIDES | BASF SE (DE) | 2014-04-23 | — | — | EP | disclosed |
| US-8604068-B2 | Insecticidal compositions of 2-cyanobenzene sulfonamide compounds and isomeric forms thereof having improved effect | BAYER CROPSCIENCE AG (DE) | 2013-12-10 | — | — | US | disclosed |
| US-8541611-B2 | Bifunctional phenyl iso(thio)cyanates, processes and intermediates products for their preparation | BASF AKTIENGESELLSCHAFT (DE) | 2013-09-24 | — | — | US | disclosed |
| EP-2157084-B1 | 5-PHENYL-3-PYRIDAZINONE DERIVATIVE | KOWA CO (JP) | 2013-05-22 | — | — | EP | disclosed |
| EP-1888509-B1 | BENZOYL-SUBSTITUTED SERINE AMIDES | BASF SE (DE) | 2013-05-15 | — | — | EP | disclosed |
| EP-2537829-A1 | Aminobenzoylsulfamides and their preparation | BASF SE (DE) | 2012-12-26 | — | — | EP | disclosed |
| EP-2534952-A1 | Insecticide compositions of 2-cyanobenzolsulfonamides and their isomeric forms with improved properties | Bayer CropScience AG (DE) | 2012-12-19 | — | — | EP | disclosed |
| US-20120302441-A1 | HERBICIDAL MIXTURES | BASF AKTIENGESELLSCHAFT (DE) | 2012-11-29 | — | — | US | disclosed |
| WO-1996001256-A1 | USE OF 2-[(DIHYDRO)PYRAZOLYL-3'-OXYMETHYLENE]-ANILIDES AS PEST-CONTROL AGENTS AND FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-01-18 | — | — | WO | disclosed |
| WO-1995029896-A1 | ALPHA-(PYRAZOL-3-YL)-OXYMETHYLENE-PHENYLBUTENIC ACID METHYL ESTERS AND THE USE THEREOF AGAINST HARMFUL FUNGI OR ANIMAL PESTS | BASF AKTIENGESELLSCHAFT (DE) | 1995-11-09 | — | — | WO | disclosed |
| US-5416068-A | Alpha-phenylacrylic acid derivatives, their preparation and their use for controlling pests and harmful fungi | BASF AKTIENGESELLSCHAFT (DE) | 1995-05-16 | — | — | US | disclosed |
| EP-0628026-A1 | CYANO-OXIME ETHERS, PROCESS FOR PRODUCING THEM, AGENTS CONTAINING THEM AND THEIR USE. | BASF AG (DE) | 1994-12-14 | — | — | EP | disclosed |
| WO-1994019331-A1 | ORTHO-SUBSTITUTED 2-METHOXYIMINOPHENYLACETIC ACID METHYLAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 1994-09-01 | — | — | WO | disclosed |
| WO-1993022280-A1 | SUBSTITUTED CYCLOHEXENE-1,2-BICARBOXYLIC ACID DERIVATIVES AND RAW MATERIALS FOR PRODUCING THEM | BASF AKTIENGESELLSCHAFT (DE) | 1993-11-11 | — | — | WO | disclosed |
| WO-1993016985-A1 | CYANO-OXIME ETHERS, PROCESS FOR PRODUCING THEM, AGENTS CONTAINING THEM AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1993-09-02 | — | — | WO | disclosed |
| EP-0513580-A2 | Alpha-phenyl-acrylic acid derivatives, process for their preparation and their use as parasiticides and fungicides | BASF Aktiengesellschaft (DE) | 1992-11-19 | — | — | EP | disclosed |
| EP-0476607-A2 | 2-Anilino-cyanopyridines and their use for pest control | BASF Aktiengesellschaft (DE) | 1992-03-25 | — | — | EP | disclosed |
| EP-0475158-A2 | Use of alpha aryl acrylic acid derivatives for pest control | BASF Aktiengesellschaft (DE) | 1992-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302441-A1 | HERBICIDAL MIXTURES | RYR2, DDT, P2RX6 | ADH1C 1161/4885ADH1A 3144/4885ADH4 3500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.